MT2A and cancer: The Kaplan–Meier analysis indicated that patients with a high expression of MT2A in the cancer stroma had significantly shorter OS (p = 0.046) and tended to have a shorter DFS (p = 0.066), while patients with a high expression of MT2A in the cancer nest had a significantly shorter CSS (p = 0.015) (Figure 6C,D).